nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—osteoarthritis	0.966	1	CbGaD
Lumiracoxib—Tolmetin—CXCL8—osteoarthritis	0.00448	0.339	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—osteoarthritis	0.00247	0.187	CrCbGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00203	0.0959	CbGpPWpGaD
Lumiracoxib—Bromfenac—PTGS2—osteoarthritis	0.00195	0.147	CrCbGaD
Lumiracoxib—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—osteoarthritis	0.00161	0.0761	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00132	0.0623	CbGpPWpGaD
Lumiracoxib—Tolmetin—PTGS2—osteoarthritis	0.00131	0.0989	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—osteoarthritis	0.00129	0.0975	CrCbGaD
Lumiracoxib—PTGS2—Eicosanoid Synthesis—PTGES—osteoarthritis	0.00105	0.0495	CbGpPWpGaD
Lumiracoxib—Mefenamic acid—PTGS2—osteoarthritis	0.001	0.0758	CrCbGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000734	0.0346	CbGpPWpGaD
Lumiracoxib—Diclofenac—PTGS2—osteoarthritis	0.00072	0.0545	CrCbGaD
Lumiracoxib—CYP1A2—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000598	0.0282	CbGpPWpGaD
Lumiracoxib—PTGS2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000583	0.0275	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CRP—osteoarthritis	0.000466	0.022	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—FN1—osteoarthritis	0.00043	0.0203	CbGpPWpGaD
Lumiracoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—osteoarthritis	0.000429	0.0202	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000423	0.02	CbGpPWpGaD
Lumiracoxib—UGT1A9—Phase II conjugation—GSTO1—osteoarthritis	0.000404	0.019	CbGpPWpGaD
Lumiracoxib—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—osteoarthritis	0.000399	0.0188	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000386	0.0182	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CRP—osteoarthritis	0.00037	0.0174	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—SOX9—osteoarthritis	0.00036	0.017	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—FN1—osteoarthritis	0.000341	0.0161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.00033	0.0156	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—PTGS2—osteoarthritis	0.000312	0.0147	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000303	0.0143	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.000265	0.0125	CbGpPWpGaD
Lumiracoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000264	0.0124	CbGpPWpGaD
Lumiracoxib—PTGS1—Eicosanoid Synthesis—PTGS2—osteoarthritis	0.000259	0.0122	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.00024	0.0113	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—GSTO1—osteoarthritis	0.000236	0.0111	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000233	0.011	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.000217	0.0102	CbGpPWpGaD
Lumiracoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000212	0.01	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—osteoarthritis	0.000211	0.00995	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—GSTO1—osteoarthritis	0.000193	0.00908	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000191	0.009	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000176	0.00829	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00017	0.00804	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.00017	0.00803	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000167	0.0079	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.000148	0.00698	CbGpPWpGaD
Lumiracoxib—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000144	0.0068	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.000137	0.00645	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000137	0.00644	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000135	0.00637	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000129	0.00607	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000128	0.00602	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—GSTO1—osteoarthritis	0.000111	0.00524	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000111	0.00523	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—GSTO1—osteoarthritis	0.000109	0.00517	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000108	0.00512	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000105	0.00495	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000103	0.00484	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000101	0.00478	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	9.98e-05	0.00471	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	9.64e-05	0.00455	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	9.16e-05	0.00432	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	8.65e-05	0.00408	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	8.53e-05	0.00403	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	8.53e-05	0.00402	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	8.4e-05	0.00396	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	8.33e-05	0.00393	CbGpPWpGaD
Lumiracoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	8.3e-05	0.00392	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	8.25e-05	0.00389	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	7.72e-05	0.00364	CbGpPWpGaD
Lumiracoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	7.57e-05	0.00357	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—FMOD—osteoarthritis	7.03e-05	0.00332	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	6.92e-05	0.00326	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	6.77e-05	0.00319	CbGpPWpGaD
Lumiracoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	6.47e-05	0.00305	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	6.44e-05	0.00304	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	6.19e-05	0.00292	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.05e-05	0.00285	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGES—osteoarthritis	5.73e-05	0.00271	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—FMOD—osteoarthritis	5.73e-05	0.00271	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	5.58e-05	0.00263	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	5.52e-05	0.0026	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	5.45e-05	0.00257	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FMOD—osteoarthritis	5.43e-05	0.00256	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—osteoarthritis	5.42e-05	0.00256	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	5.35e-05	0.00253	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	5.05e-05	0.00238	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	5e-05	0.00236	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	4.99e-05	0.00236	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	4.91e-05	0.00232	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IHH—osteoarthritis	4.84e-05	0.00229	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	4.72e-05	0.00223	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	4.71e-05	0.00222	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGES—osteoarthritis	4.67e-05	0.00221	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	4.67e-05	0.0022	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	4.67e-05	0.0022	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—FMOD—osteoarthritis	4.55e-05	0.00215	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	4.16e-05	0.00196	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GSTO1—osteoarthritis	4.04e-05	0.00191	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	3.96e-05	0.00187	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—BGN—osteoarthritis	3.91e-05	0.00185	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	3.88e-05	0.00183	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTGES—osteoarthritis	3.71e-05	0.00175	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFBI—osteoarthritis	3.61e-05	0.0017	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FMOD—osteoarthritis	3.31e-05	0.00156	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTO1—osteoarthritis	3.29e-05	0.00155	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—BGN—osteoarthritis	3.19e-05	0.0015	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	3.13e-05	0.00148	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GSTO1—osteoarthritis	3.12e-05	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BGN—osteoarthritis	3.02e-05	0.00143	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FMOD—osteoarthritis	3.01e-05	0.00142	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	2.83e-05	0.00134	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGES—osteoarthritis	2.69e-05	0.00127	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	2.64e-05	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTO1—osteoarthritis	2.61e-05	0.00123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FMOD—osteoarthritis	2.58e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BGN—osteoarthritis	2.53e-05	0.00119	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.53e-05	0.00119	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGES—osteoarthritis	2.46e-05	0.00116	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGES—osteoarthritis	2.1e-05	0.000991	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.06e-05	0.000971	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTO1—osteoarthritis	1.9e-05	0.000896	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BGN—osteoarthritis	1.84e-05	0.000868	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTO1—osteoarthritis	1.73e-05	0.000817	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BGN—osteoarthritis	1.68e-05	0.000791	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SMAD3—osteoarthritis	1.48e-05	0.0007	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTO1—osteoarthritis	1.48e-05	0.000698	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BGN—osteoarthritis	1.43e-05	0.000676	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.19e-05	0.00056	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—osteoarthritis	1.12e-05	0.000531	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.08e-05	0.000511	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	9.25e-06	0.000436	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—osteoarthritis	9.17e-06	0.000433	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—osteoarthritis	6.28e-06	0.000296	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—osteoarthritis	5.29e-06	0.000249	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—osteoarthritis	4.82e-06	0.000227	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—osteoarthritis	4.73e-06	0.000223	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—osteoarthritis	4.12e-06	0.000194	CbGpPWpGaD
